Agentix Stock Price, News & Analysis
Company Description
Agentix (OTC Link: AGTX) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.7M.
AGTX stock has declined 41.3% over the past year. Shares last traded at $0.0410.
On a trailing twelve-month basis, Agentix reported net income of -$567K and diluted earnings per share of $-0.01.
This page provides a comprehensive overview of AGTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Agentix (AGTX) stock last traded at $0.0410. Over the past 12 months, the stock has lost 41.3%. At a market capitalization of $1.7M, AGTX is classified as a micro-cap stock with approximately 40.1M shares outstanding.
Latest News
SEC Filings
Agentix has filed 2 recent SEC filings, including 2 Form 10-Q. The most recent filing was submitted on February 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AGTX SEC filings →
Financial Highlights
operating income reached -$513K, and net income was -$567K. Diluted earnings per share stood at $-0.01. The company generated -$125K in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Agentix (AGTX) currently stands at 13 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Agentix (AGTX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
AGTX Company Profile & Sector Positioning
Agentix (AGTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.